These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension. Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678 [TBL] [Abstract][Full Text] [Related]
6. The effect of captopril on severe renin-dependent hypertension of uraemics on regular dialysis treatment. Pyrpasopoulos M; Sion M; Paraskevopoulos G; Zuruzoglu W; Paradelis AG Methods Find Exp Clin Pharmacol; 1983; 5(2):131-4. PubMed ID: 6348445 [TBL] [Abstract][Full Text] [Related]
7. Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent. Rubin B; Antonaccio MJ; Horovitz ZP Prog Cardiovasc Dis; 1978; 21(3):183-94. PubMed ID: 214818 [No Abstract] [Full Text] [Related]
9. [Successful treatment of renal hypertension in a 2 1/2-year-old girl with the converting enzyme inhibitor captopril (author's transl)]. Lütkenhaus C; Bonzel K; Diekmann L; Koch H Monatsschr Kinderheilkd; 1980 Nov; 128(11):724-6. PubMed ID: 6110181 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril. Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542 [TBL] [Abstract][Full Text] [Related]
11. Relief from malignant hypertension by treatment with captopril in a patient on maintenance hemodialysis. Witzgall H Klin Wochenschr; 1980 Sep; 58(17):871-3. PubMed ID: 7003235 [TBL] [Abstract][Full Text] [Related]
12. [Use of angiotensin converting enzyme inhibitors in nephrology]. Stefanović V; Ivić M; Bogićević M Srp Arh Celok Lek; 1994; 122(7-8):228-30. PubMed ID: 17974394 [TBL] [Abstract][Full Text] [Related]
14. [Effect of an oral angiotensin I-converting enzyme inhibitor on blood pressure and renin-angiotensin-aldosterone system before and after nephrectomy in two cases with acute renovascular hypertension]. Irabu N; Nakamura K; Morohashi Y; Murakami S; Kawamura K Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1029-39. PubMed ID: 6298493 [No Abstract] [Full Text] [Related]
15. Enalapril treatment in a patient with impaired renal function and intolerance to captopril. Lindsjö M; Danielson BG; Weiss L; Wikström B Scand J Urol Nephrol Suppl; 1984; 79():99-101. PubMed ID: 6089326 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor. Sweet CS; Gross DM; Arbegast PT; Gaul SL; Britt PM; Ludden CT; Weitz D; Stone CA J Pharmacol Exp Ther; 1981 Mar; 216(3):558-66. PubMed ID: 6259323 [No Abstract] [Full Text] [Related]
17. Converting enzyme inhibitors in hemodialysis. Bazilinski N Int J Artif Organs; 1983 Mar; 6(2):62-4. PubMed ID: 6302010 [No Abstract] [Full Text] [Related]
18. Influence of various antihypertensive agents on lifespan of renal hypertensive rats. Horovitz ZP; Antonaccio MJ; Rubin B; Panasevich RE Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):243S-248S. PubMed ID: 465290 [TBL] [Abstract][Full Text] [Related]
19. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity. Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756 [TBL] [Abstract][Full Text] [Related]
20. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs. Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]